Character Traits and Stress in Suspected Prostate Cancer

It has previously been reported that men with prostate cancer are 1 ) reduced quality of life after diagnosis and treatment, 2 ) neuroticism increases the reduction in QoL related to treatment side effects, and 3) often have very involved and active spouses who seems to have been handed over / taken over parts of the men's responsibility for their own health. We postulate herein a new hypothesis that the stress level is elevated when harbouring undetected prostate cancer. We will investigate whether those who are diagnosed with prostate cancer already in beforehand have an increased degree of masculine stress ( experience of not living up to their own perception of the ideal man ) and neuroticism in the typology. We will examine different personality and QoL questionnaires for patients with elevated PSA, and compare those whose clinical assessment later reveals prostate cancer, with three control groups: 1) men with elevated PSA who are not diagnosed with prostate cancer, 2) men with normal PSA treated for benign prostate enlargement and 3) patient with substantial risk of colorectal cancer (CRC) who undergo colonoscopy, with regard to increased level of masculine stress and the personality trait neuroticism.

Sex

Male

Minimum age

18 Years

Maximum age

75 Years

Inclusion Criteria:

1. Men who be referred a new urological outpatient and satisfy the following:

   * Wanted examined because of elevated PSA
   * Not strong family history of prostate cancer
   * It is taken biopsy as part of routine investigation.
2. Control group: Men referred to urological outpatient clinic, and who satisfy the following

   * urination complaints
   * Normal PSA
   * examination shows prostate size\> 40cc
3. Control group: Men first time referred urological / gastroenterological outpatient clinic, and which satisfy the following

   \-- symptoms that might indicate cancer suspicion in colorectum
4. Age\> 40 years and \<75 years

Exclusion criteria:

1. known prostate cancer
2. Reduced consent

4 Familial occurrence of prostate cancer (one or more 1st degree relatives with CaP)